UVLrx Therapeutics Receives CE Mark for Intravenous Light Therapy System

Oldsmar, Fla.-based UVLrx Therapeutics has received CE marking to sell its UVLrx 1500 multi-wavelength, intravenous light therapy system in the EU.

The LED-based system — meant to treat bacterial and viral infections — offers the first intravenous, concurrent delivery of ultraviolet-A and multiple visible light wavelengths and eliminates the need to remove blood from the body, the company says.

The device administers multiple wavelengths, each chosen for its unique therapeutic qualities, through a peripheral I.V. catheter to the passing blood supply.

The CE mark covers eight different indications, including pain reduction, removal of pathogens and immune system modulation. — Michael Cipriano